[{"uuid": "baeb90e2-bb04-3aa8-a112-40db34cc9800", "title": "Annexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough Year", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/annexon-provides-2025-outlook-strong-130000586.html", "providerPublishTime": 1736773200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ItXEwlOMql1SXE_Pu_CXhQ--~B/aD00Mjc7dz0xMjk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 1297, "height": 427, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1LENzlsOrwlO4ATSCHuhUQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANNX"]}, {"uuid": "1739af8f-1f28-3262-af0f-45dcb510de71", "title": "Annexon Expands Board of Directors with Appointment of Commercial Executive William \u201cBJ\u201d Jones", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/annexon-expands-board-directors-appointment-130000694.html", "providerPublishTime": 1736514000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ItXEwlOMql1SXE_Pu_CXhQ--~B/aD00Mjc7dz0xMjk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 1297, "height": 427, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1LENzlsOrwlO4ATSCHuhUQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANNX"]}, {"uuid": "2e4d7bc2-eb42-3450-bbee-241cce0c76ac", "title": "Annexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/annexon-biosciences-present-43rd-annual-130000420.html", "providerPublishTime": 1736254800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ItXEwlOMql1SXE_Pu_CXhQ--~B/aD00Mjc7dz0xMjk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 1297, "height": 427, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1LENzlsOrwlO4ATSCHuhUQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANNX"]}, {"uuid": "e64c283c-f863-3d68-8dfc-a08c8dd5698d", "title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/annexon-reports-inducement-grants-employees-210500604.html", "providerPublishTime": 1734383100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ItXEwlOMql1SXE_Pu_CXhQ--~B/aD00Mjc7dz0xMjk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 1297, "height": 427, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1LENzlsOrwlO4ATSCHuhUQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANNX"]}, {"uuid": "82ce3098-3e86-300a-96ae-d679bc5ca85e", "title": "Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barr\u00e9 Syndrome (GBS)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/annexon-announces-positive-topline-results-123000121.html", "providerPublishTime": 1734352200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ItXEwlOMql1SXE_Pu_CXhQ--~B/aD00Mjc7dz0xMjk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 1297, "height": 427, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1LENzlsOrwlO4ATSCHuhUQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANNX"]}, {"uuid": "135162c1-91a1-3886-bbb3-587bcd17dc7a", "title": "Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/annexon-present-phase-2-archer-130000087.html", "providerPublishTime": 1733403600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ItXEwlOMql1SXE_Pu_CXhQ--~B/aD00Mjc7dz0xMjk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 1297, "height": 427, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1LENzlsOrwlO4ATSCHuhUQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANNX"]}, {"uuid": "96fd59bd-21a8-3d0d-9102-3fa02fc2ccb9", "title": "Annexon Biosciences to Present at the Jefferies London Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/annexon-biosciences-present-jefferies-london-210500268.html", "providerPublishTime": 1731531900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ItXEwlOMql1SXE_Pu_CXhQ--~B/aD00Mjc7dz0xMjk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 1297, "height": 427, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1LENzlsOrwlO4ATSCHuhUQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANNX"]}, {"uuid": "dc422026-336f-3a88-8c96-04e0027cf739", "title": "Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/annexon-reports-third-quarter-2024-130000012.html", "providerPublishTime": 1731589200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ItXEwlOMql1SXE_Pu_CXhQ--~B/aD00Mjc7dz0xMjk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 1297, "height": 427, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1LENzlsOrwlO4ATSCHuhUQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/de895f17115cacfacdd391d1d319d881", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANNX"]}, {"uuid": "6ab1cd5a-89f6-3f67-bd16-060cee2326d3", "title": "The Dodgers\u2019 World Series run brought attention to a rare disease. Annexon is stepping up to the plate.", "publisher": "Pharma Voice", "link": "https://finance.yahoo.com/m/6ab1cd5a-89f6-3f67-bd16-060cee2326d3/the-dodgers%E2%80%99-world-series-run.html", "providerPublishTime": 1732003200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/JDXLduIcc_MHKs4Cv2pGYg--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/ebe272ab58bd5f4860f49994e2412f2a", "width": 1280, "height": 720, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/cuvbLlOlbSceNbN3YhwgRg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/ebe272ab58bd5f4860f49994e2412f2a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANNX"]}]